1. Home
  2. CRNX vs MWA Comparison

CRNX vs MWA Comparison

Compare CRNX & MWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$83.99

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo MUELLER WATER PRODUCTS

MWA

MUELLER WATER PRODUCTS

HOLD

Current Price

$26.56

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
MWA
Founded
2008
1857
Country
United States
United States
Employees
N/A
3500
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
CRNX
MWA
Price
$83.99
$26.56
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
$76.75
$30.50
AVG Volume (30 Days)
6.8M
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
1.01%
EPS Growth
N/A
64.86
EPS
N/A
0.65
Revenue
$1,039,000.00
$1,429,700,000.00
Revenue This Year
$720.10
$4.78
Revenue Next Year
$184.67
$4.27
P/E Ratio
N/A
$39.68
Revenue Growth
N/A
8.75
52 Week Low
$25.83
$22.74
52 Week High
$84.00
$31.00

Technical Indicators

Market Signals
Indicator
CRNX
MWA
Relative Strength Index (RSI) 90.37 N/A
Support Level $43.40 N/A
Resistance Level $84.00 N/A
Average True Range (ATR) 0.19 0.00
MACD -1.64 0.00
Stochastic Oscillator 71.70 0.00

Price Performance

Historical Comparison
CRNX
MWA

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About MWA MUELLER WATER PRODUCTS

Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.

Share on Social Networks: